Medical Economics Pulse

25: Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment

3 min · 15. elo 2025
jakson 25: Weekly Dose: New Endocrine Guidelines, Digital Asthma Gains, AI Trust Gap, GLP-1 & Dementia Risk, First CHE Treatment kansikuva

Kuvaus

This week’s Weekly Dose covers new Endocrine Society guidelines on preexisting diabetes in pregnancy and primary aldosteronism screening, a digital asthma management tool that improved symptoms but revealed disparities, public perceptions of physicians using AI, evidence linking GLP-1 receptor agonists to reduced dementia risk, and the FDA’s first approved treatment for chronic hand eczema.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity Medical Economics Pulse-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

28 jaksot

jakson 30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes kansikuva

30: Weekly Dose Podcast: Depression Risk After Chronic Illness, Vaginal Estradiol Safety, GLP-1 Updates, Cancer Risk Reduction, and CVD Outcomes

In this episode of the Weekly Dose podcast by Patient Care Online, we review recent studies on key clinical topics: the heightened risk of depression after chronic illness diagnosis, the safety of vaginal estradiol for women with prior stroke, the approval of generic liraglutide for obesity, the potential cancer risk reduction with GLP-1 therapies, and cardiovascular benefits of semaglutide in patients with obesity. The episode highlights important findings and their implications for clinical practice, offering health care professionals timely updates across mental health, women’s health, obesity management, cancer prevention, and cardiovascular care.

24. syys 20254 min